<bill session="116" type="h" number="5668" updated="2023-01-11T13:44:19Z">
  <state datetime="2020-11-17T12:25:02-05:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2020-11-17T12:25:02-05:00"/>
  </status>
  <introduced datetime="2020-01-24"/>
  <titles>
    <title type="display">MODERN Labeling Act of 2020</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to modernize the labeling of certain generic drugs, and for other purposes.</title>
    <title type="short" as="reported to house">Making Objective Drug Evidence Revisions for New Labeling Act of 2020</title>
    <title type="short" as="reported to house">MODERN Labeling Act of 2020</title>
    <title type="short" as="introduced">Making Objective Drug Evidence Revisions for New Labeling Act of 2020</title>
    <title type="short" as="introduced">MODERN Labeling Act of 2020</title>
    <title type="short" as="passed house">Making Objective Drug Evidence Revisions for New Labeling Act of 2020</title>
    <title type="short" as="passed house">Making Objective Drug Evidence Revisions for New Labeling Act of 2020</title>
    <title type="short" as="passed house">MODERN Labeling Act of 2020</title>
    <title type="short" as="passed house">MODERN Labeling Act of 2020</title>
  </titles>
  <sponsor bioguide_id="M001163"/>
  <cosponsors>
    <cosponsor bioguide_id="G000558" joined="2020-01-24"/>
    <cosponsor bioguide_id="T000479" joined="2020-11-16"/>
  </cosponsors>
  <actions>
    <action datetime="2020-01-24">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-01-24" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2020-01-25">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2020-03-11" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </action>
    <action datetime="2020-03-11">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2020-07-15">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2020-07-15">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </action>
    <action datetime="2020-11-16">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-573.</text>
    </action>
    <calendar datetime="2020-11-16" calendar="Union" number="471">
      <text>Placed on the Union Calendar, Calendar No. 471.</text>
    </calendar>
    <action datetime="2020-11-17T12:17:23-05:00">
      <text>Mr. Pallone moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2020-11-17T12:17:58-05:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H5805-5807" label="consideration"/>
    </action>
    <action datetime="2020-11-17T12:18:02-05:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 5668.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2020-11-17T12:25:02-05:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H5805-5806" label="text"/>
    </vote>
    <action datetime="2020-11-17T12:25:13-05:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2020-11-18">
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="1895" relation="unknown"/>
    <bill session="116" type="s" number="1897" relation="unknown"/>
    <bill session="116" type="s" number="4796" relation="unknown"/>
    <bill session="116" type="h" number="8527" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-07T15:13:18Z" status="Passed House">Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020

This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.</summary>
  <committee-reports>
    <report>H. Rept. 116-573</report>
  </committee-reports>
</bill>
